Sponsor Dossier

Pharmaco

Sponsor Dossier for Pharmaco. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.

About

Pharmaco is an Other Incorporated Entity with ABN 89 113 383 501, registered in Australia and currently active.

Portfolio

Pharmaco has 22 brands on the ARTG, of which 20 are indexable and 20 carry a Product Information document. 14 brands are PBS-listed, 1 has a PBAC outcome on record, and 1 has an AusPAR on record. Notable brands include ACIMAX, ANAFRANIL, ANEXATE, CYMEVENE, DILATREND, HYPNOVEL, KONAKION MM, LARIAM, LEXOTAN, LOSEC, OMEPRAL, OTODEX.

Therapeutic focus

— Psychiatry: 4 brands — Infectious Disease: 4 brands — Gastroenterology: 3 brands — Neurology: 2 brands — Pain Management: 2 brands — Haematology: 1 brand — Oncology: 1 brand — Cardiology: 1 brand — Endocrinology: 1 brand — Ophthalmology: 1 brand — Other: 1 brand — Dermatology: 1 brand

PBS footprint

14 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.

Regulatory activity

The latest PBAC outcome is 2009-07-01, across 1 brand with a PBAC outcome on record. The latest AusPAR is 2016-01-06, across 1 brand with an AusPAR on record.

ABR record